Antiretroviral pipeline: new-drug reports from retroviruses conference.
James
John S
JS
D019380:Anti-HIV Agents / Q000494:pharmacology; D065100:CCR5 Receptor Antagonists; D003570:Cytidine Triphosphate / Q000031:analogs & derivatives / Q000494:pharmacology; D024882:Drug Resistance, Viral; D006678:HIV / Q000187:drug effects / Q000502:physiology; D023581:HIV Fusion Inhibitors / Q000494:pharmacology; D008561:Membrane Fusion / Q000187:drug effects; D016047:Zalcitabine / Q000031:analogs & derivatives
D019380:Anti-HIV Agents; D065100:CCR5 Receptor Antagonists; D023581:HIV Fusion Inhibitors; D003570:Cytidine Triphosphate; D016047:Zalcitabine; C099405:dexelvucitabine